Publications by authors named "K Fukushi"
Bone-modifying agents (BMAs) have been widely used to reduce skeletal-related events, including pathological fractures. Herein, we aimed to clarify the incidence of pathological fractures caused by high-risk femoral bone metastases after palliative radiotherapy (RT) in the BMA era and evaluate the necessity of prophylactic surgical stabilization. We assessed 90 patients with high-risk femoral bone metastases, indicated by Mirels' scores ≥ 8, without pathological fractures and surgical fixations, who received palliative RT at our institution between January 2009 and December 2018.
View Article and Find Full Text PDFA new type of sphincterotome released to the market recently has high rotation performance and a freely bendable blade. It is devised to be singly capable of accommodating not only normal anatomy but also cases with surgically altered anatomy. This study was undertaken for clinical evaluation of the usefulness of this new sphincterotome.
View Article and Find Full Text PDFArticle Synopsis
- * Various embolic materials like tissue adhesives and coils are being used effectively in these treatments, showing positive clinical results.
- * Research is exploring the feasibility of performing advanced procedures like portal vein stenting via EUS, indicating potential for future development despite current studies being mostly in animals.
Introduction: This case study aimed to demonstrate how cooking class activities held in collaboration with the Ajinomoto Foundation (TAF) and a consumer cooperative after the Great East Japan Earthquake contributed to the resilience of the affected community.
Methods: With reference to the logic model, evaluation indicators for the case study were established. We focused on the Iwate Seikatsu Kyodo Kumiai (Iwate Co-op).
Article Synopsis
- - This study investigated the acute toxicity of hypo-fractionated radiotherapy in Japanese breast cancer patients post-surgery, focusing on two treatment cohorts: moderately hypo-fractionated (Cohort M) and ultra-hypo-fractionated (Cohort U).
- - A total of 123 patients were evaluated over 90 days after treatment, with the most common acute adverse events being grade 1 and 2, and no grade 3 or higher events reported.
- - The study concluded that the rates of acute toxicity from these radiotherapy methods were considered acceptable, with 15% for Cohort M and 10% for Cohort U experiencing grade 2 or higher adverse events.